10-Deacetyl-7-xylosyl paclitaxel

For research use only. Not for therapeutic Use.

  • CAT Number: I005402
  • CAS Number: 90332-63-1
  • Molecular Formula: C50H57NO17
  • Molecular Weight: 943.98
  • Purity: ≥95%
Inquiry Now

10-Deacetyl-7-xylosyl paclitaxel(Cat No.:I005402)is a modified form of paclitaxel, a widely used anticancer drug derived from the Pacific yew tree. This derivative has been chemically modified to improve its pharmacological properties, particularly its water solubility. By attaching a xylosyl group to the 7-position of the paclitaxel molecule and removing the acetyl group at the 10-position, 10-Deacetyl-7-xylosyl paclitaxel exhibits enhanced solubility in water compared to paclitaxel. This improved water solubility can potentially facilitate its formulation and administration in clinical settings, leading to better drug delivery and therapeutic efficacy. Further studies are being conducted to explore its potential applications in cancer treatment.


Catalog Number I005402
CAS Number 90332-63-1
Molecular Formula C50H57NO17
Purity ≥95%
Target Cytoskeleton
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChI InChI=1S/C50H57NO17/c1-25-31(65-45(61)38(56)35(27-15-9-6-10-16-27)51-43(59)28-17-11-7-12-18-28)22-50(62)42(67-44(60)29-19-13-8-14-20-29)40-48(5,41(58)37(55)34(25)47(50,3)4)32(21-33-49(40,24-64-33)68-26(2)52)66-46-39(57)36(54)30(53)23-63-46/h6-20,30-33,35-40,42,46,53-57,62H,21-24H2,1-5H3,(H,51,59)/t30-,31+,32+,33-,35+,36+,37-,38-,39-,40+,42+,46+,48-,49+,50-/m1/s1
InChIKey ORKLEZFXASNLFJ-DYLQFHMVSA-N
SMILES CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)C)O
Reference

<p style=/line-height:25px/>
<br>[1]. Jiang S, et al. Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol. 2008 Jul;33(1):103-11.

</p>

Request a Quote